1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
675C34B5FC25F85BA00258C5B001EE402
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/75C34B5FC25F85BA00258C5B001EE402?OpenDocument
18
19OpenDocument
2018.97.9.170
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Communication

Document Excerpt: Improving Medical Affairs Booth Impact at CNS Congresses: Information Availability and Poster/Investigator Receptions

DB Image

Excerpt in Cart

ID: MD-965


Features:

10 Info Graphics

10 Data Graphics

210+ Metrics

9 Narratives


Pages/Slides: 4


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5865 “Improving Medical Affairs Booth Impact at CNS Congresses: Information Availability and Poster/Investigator Receptions”.

Industries Profiled:
Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Biopharmaceutical; Health Care


Companies Profiled:
Amgen; Astellas; Bayer; Chiesi Global Rare Diseases; EMD Serono; Ipsen; Incyte; Morphic Therapeutic; Novartis; OPEN Health; Protagonist Therapeutics; Purdue Pharma; Regeneron; Takeda Pharmaceuticals; Teva Pharmaceuticals; Vertex Pharmaceuticals; Xenon Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.